Navigation Links
Quality standards for biological, chemical drugs and public health are focus of India meeting
Date:1/24/2011

Rockville, Md., January 24, 2011 In collaboration with key stakeholders, the United States Pharmacopeial Convention (USP) and the Indian Pharmacopoeia Commission (IPC) will host the 2011 IPC-USP 10th Science & Standards Symposium on February 17 and 18, 2011 in Hyderabad, India. The event reflects India's rise as a supplier of medicines worldwide, bringing USP closer to its Indian counterpart in the interest of promoting global public health.

The symposium aims to facilitate a science-based dialogue among key stakeholderssuch as standard-setting bodies, government officials, policy makers, pharmaceutical manufacturers and academiato address relevant topics affecting the region and thereby promote access to quality medicines. Attendees will have the opportunity to network with thought leaders, obtain industry benchmark information and contribute early in the standard-setting process for both IPC and USP.

Along with USP and IPC, additional co-sponsors include Bulk Drug Manufacturers Association (BDMA), Indian Drug Manufacturers' Association (IDMA), Organization of Pharmaceutical Producers of India (OPPI) and Pharmacy Council of India (PCI).

"For a decade, these annual IPC-USP meetings have brought together key experts and innovators throughout the Indian pharmaceutical landscape as well from the United States and other countries," said Roger L. Williams, M.D., chief executive officer, USP. "As India's role in the global pharmaceutical industry continues its rapid growth, collaborations within India and with partners around the world are essential to helping to ensure public health." Previous events were known as Annual Scientific Meetings.

Sessions on chemical drugs will be part of symposium highlights, covering topics as varied as quality by design, standards-setting, impurities, chemical reference materials/uncertainty measurement and strategies for combating counterfeit drugs. Biological drugs will also be emphasized in sessions that explore regulatory approaches; standards for biologics and biotechnology drugs; critical quality attributes; reference materials; standards for vaccines and monoclonal antibodies and strategies for combating adulteration of drugs.

"The IPC values its longstanding relationship with USP," stated G.N. Singh, Ph.D., secretary-cum-scientific director, IPC. "We are confident this year's forum will result in a better understanding among participants of the status and issues facing the IPC and USP in standards-setting."


'/>"/>

Contact: Theresa Laranang-Mutlu
trl@usp.org
301-816-8167
US Pharmacopeia
Source:Eurekalert

Related biology news :

1. CU-Boulder study suggests air quality regulations miss key pollutants
2. Biological sand filters, a practical approach to combat poverty and inequality
3. New standard for popular stevia-based sweetener to assure products quality
4. New research shows high-quality protein in eggs contributes to power, strength and energy
5. Healthy food availability could depend on where you live -- so does the quality of your diet
6. Houseplants increase quality of life for retirement community residents
7. Enhanced quality of LIFE through Nordic food
8. Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution
9. Quality and purity of popular stevia sweetener strengthened by new reference standards
10. Dietary supplements manufacturers gain new tool to help ensure quality products
11. Improved air quality during Beijing Olympics could inform pollution-curbing policies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... ... October 10, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, announces a presentation ... San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting ... a professor in Harvard University’s Departments of Physics and Astronomy, has been selected for ... of the winning team for the 2015 Breakthrough Prize in Fundamental physics for the ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C ... software to perform Hi-C metagenome deconvolution using their own facilities, supplementing the ...
(Date:10/5/2017)... CA (PRWEB) , ... October 05, 2017 , ... ... engineers, and scientists from around the world, is giving back to cancer research with ... in October. , Now through October 31, shoppers can use promo code PinkRibbon ...
Breaking Biology Technology: